Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

UNITED THERAPEUTICS (UTHR) Interest & Investment Income: 2009-2024

Historic Interest & Investment Income for UNITED THERAPEUTICS (UTHR) over the last 14 years, with Dec 2024 value amounting to $199.1 million.

  • UNITED THERAPEUTICS's Interest & Investment Income fell 6.83% to $46.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $198.1 million, marking a year-over-year decrease of 1.34%. This contributed to the annual value of $199.1 million for FY2024, which is 22.37% up from last year.
  • Latest data reveals that UNITED THERAPEUTICS reported Interest & Investment Income of $199.1 million as of FY2024, which was up 22.37% from $162.7 million recorded in FY2023.
  • In the past 5 years, UNITED THERAPEUTICS's Interest & Investment Income registered a high of $199.1 million during FY2024, and its lowest value of $16.7 million during FY2021.
  • In the last 3 years, UNITED THERAPEUTICS's Interest & Investment Income had a median value of $162.7 million in 2023 and averaged $135.7 million.
  • In the last 5 years, UNITED THERAPEUTICS's Interest & Investment Income crashed by 41.61% in 2021 and then spiked by 259.96% in 2023.
  • UNITED THERAPEUTICS's Interest & Investment Income (Yearly) stood at $28.6 million in 2020, then slumped by 41.61% to $16.7 million in 2021, then skyrocketed by 170.66% to $45.2 million in 2022, then spiked by 259.96% to $162.7 million in 2023, then climbed by 22.37% to $199.1 million in 2024.